Transforming cross-linked cyclic dimers of kr-12 into stable and potent antimicrobial drug leads

HIGHLIGHTS

  • who: Taj Muhammad et al. from the Pharmacognosy, Department of Pharmaceutical Biosciences, Biomedical Centre, University, Box , have published the article: Transforming Cross-Linked Cyclic Dimers of KR-12 into Stable and Potent Antimicrobial Drug Leads, in the Journal: Biomedicines 2023, 504 of /2023/
  • what: To giving further insight into the structure-activity relationship of KR-12 this work shows that by combining peptide stabilization strategies (dimerization backbone cyclization and cross-linking via a disulfide bond) KR-12 can be engineered into a peptide lead with potential utility in a therapeutic context. The aim of this . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?